Physician

Andrew K. Day, M.D.

According to 2025 Medicare claims, Andrew Day, M.D. (NPI: 1891791695) practices interventional cardiology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is WACO CARDIOLOGY ASSOCIATES (NPI: 1982607735; TIN: 74-1784088) and primary practice location at 76712-4054. Day is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Day's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,256 traditional Medicare patients, billed 9,152 HCPCS/CPT codes, and received $696,220 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 15,393 prescription claims across 1,344 beneficiaries totaling $1,386,109 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 31 claims. Open Payments data shows 12 records totaling $258. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $665,590 to $696,220. In contrast, Part D prescription costs have moved sharply higher in recent years, from $465,161 to $1,386,109. For DME billing, this smaller-volume category moved sharply higher in recent years, from $11,549 to $25,313.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,978	15,239	$665,590
2016	5,179	26,029	$958,650
2017	5,188	23,808	$863,537
2018	4,288	19,275	$762,788
2019	3,917	11,490	$701,208
2020	3,233	11,620	$647,590
2021	3,208	9,625	$653,261
2022	2,908	6,553	$498,893
2023	2,918	6,536	$511,575
2024	3,256	9,152	$696,220

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	763	11,194	$465,161
2016	914	12,492	$535,130
2017	1,005	13,538	$575,029
2018	1,067	12,716	$568,231
2019	1,109	12,700	$669,891
2020	1,119	13,239	$842,844
2021	1,178	13,233	$878,341
2022	1,215	14,110	$1,031,574
2023	1,253	14,938	$1,277,656
2024	1,344	15,393	$1,386,109

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$23,463
2017	N/R	12	$26,375
2018	13	31	$65,265
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	609	614	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	880	1,064	$85
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	582	800	$21
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	738	967	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	979	1,096	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	811	33,579	$633,572
Repatha Sureclick	Evolocumab	211	7,606	$145,643
Xarelto	Rivaroxaban	121	6,420	$113,461
Entresto	Sacubitril/Valsartan	92	3,812	$81,313
Nexlizet	Bempedoic Acid/Ezetimibe	102	3,840	$49,920

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$258	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew K. Day, M.D.?

Tedicare shows public-source Medicare data for Andrew K. Day, M.D. (NPI 1891791695), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew K. Day, M.D. have ACO affiliation data?

Andrew K. Day, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Andrew K. Day, M.D.?

Andrew K. Day, M.D. is linked to WACO CARDIOLOGY ASSOCIATES (billing NPI 1982607735) in the available physician profile data.

Does Andrew K. Day, M.D. have Open Payments data?

Andrew K. Day, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.